Characterization of an Aedes ADP-Ribosylation Protein Domain and Role of Post-Translational Modification during Chikungunya Virus Infection

Poly ADP-ribose polymerases (PARPs) catalyze ADP-ribosylation, a subclass of post-translational modification (PTM). Mono-ADP-ribose (MAR) moieties bind to target molecules such as proteins and nucleic acids, and are added as part of the process which also leads to formation of polymer chains of ADP-ribose. ADP-ribosylation is reversible; its removal is carried out by ribosyl hydrolases such as PARG (poly ADP-ribose glycohydrolase), TARG (terminal ADP-ribose protein glycohydrolase), macrodomain, etc. In this study, the catalytic domain of Aedes aegypti tankyrase was expressed in bacteria and purified. The tankyrase PARP catalytic domain was found to be enzymatically active, as demonstrated by an in vitro poly ADP-ribosylation (PARylation) experiment. Using in vitro ADP-ribosylation assay, we further demonstrate that the chikungunya virus (CHIKV) nsp3 (non-structural protein 3) macrodomain inhibits ADP-ribosylation in a time-dependent way. We have also demonstrated that transfection of the CHIKV nsP3 macrodomain increases the CHIKV viral titer in mosquito cells, suggesting that ADP-ribosylation may play a significant role in viral replication.


Introduction
ADP-ribosylation is a common modification that occurs in all life domains, including prokaryotic and eukaryotic organisms. It entails the attachment of mono or polymer units of ADP-ribose to target molecules, such as DNA, proteins, and RNA [1][2][3], and is known to play a role in a number of biological functions, including DNA damage repair, telomere maintenance, stress response, immunological response, cell signaling, and cell proliferation [4][5][6]. Three sets of proteins called writers, readers, and erasers control the process of ADP (Adenosine diphosphate)-ribosylation. The writers convert nicotinamide adenine dinucleotide (NAD + ) to nicotinamide (NAM) and ADP-ribose, then the latter attaches to target molecules. ADP-ribosyl transferases (ARTs) are commonly used for mono PARPs or Poly ADP-ribose polymerase (PARP), depending on whether they add only a single ADP-ribose (MARP) or multiple ADP-ribose units to target molecules [1,7]. Reader proteins, which contain one of the following domains such as macrodomain, WWE domain (named after three conserved single letter amino acid residues), PAR-binding motifs (PBMs), or PAR-binding zinc finger (PBZ) domain, are able to recognize ADP-ribosylation on target proteins [7]. These proteins have important roles in localization [8], DNA damage response [9], and ubiquitin-mediated proteasomal degradation [10,11] by interacting with ADP-ribosylated proteins. Eraser proteins bind to and remove ADP-ribosylation. They are divided into: terminal ADP-ribose protein glycohydrolase 1 (TARG1), poly ADP-ribose glycohydrolase (PARG), and ADP-ribosyl-acceptor hydrolases (ARH1 and ARH3). Macro

Sequence Alignment and Phylogenetic Analysis
To identify PARP orthologs in Ae. aegypti, 17 human PARPs were blast aligned against known Ae. aegypti PARPs. Sequences were aligned and a phylogenetic tree was generated using MEGA 11 software [35]. The sequence alignment was done with MUSCLE algorithm. The sequences were then analyzed for phylogenetic analysis using the following method: statistical method: maximum likelihood, test of phylogeny: bootstrap method, no. of bootstrap replication: 1000, substitution model: Poisson model, ML heuristic method: nearest-neighbor-interchange (NNI), no. of threads: 5. Next, the Aedes PARP sequences were analyzed for domains present in them using ScanProsite (https://prosite.expasy.org/scanprosite/; accessed on 16 April 2022).
A lab-adapted CHIKV clinical strain, IND-2010#01 (Accession no. JF950631.1) was used to infect Aag2 cells [37], as mentioned in a previous study [36]. Vero cells were grown to full confluency and in Aag2 cells, 1 × 10 6 cells/well in a 12-well plate were seeded. The next day, the medium in the wells was changed with serum-supplemented medium absent of antibiotics. EGFP and macrodomain cloned pIB/V5-His plasmids (1.5 µg each) were suspended in 100 µL serum-free medium with 2 µL TransIT transfection reagent (Mirus Bio LLC, Madison, WI, USA) separately and kept at RT for 20 min (minutes). The mixture was added drop-wise to cells and after 24 h (hour) the cells were infected with CHIKV at MOI (multiplicity of infection) of 1. The cells/supernatant were collected at 24, 36, and 48 hpi (hours post infection).

Protein Purification
The tankyrase catalytic domain and CHIKV nsP3 protein were purified using a previously published protocol with slight modifications [38]. E. coli cultures having plasmid encoding Ae. aegypti tankyrase catalytic domain and CHIKV nsP3 were induced with 1mM IPTG for 16-20 h at 18 • C (degree Celsius). The cultures were pelleted and lysed in the lysis buffer (Tris-Cl (pH 8.0) 50 mM (milli Molar), NaCl 150 mM, EDTA 2 mM, glycerol 5%, β-mercaptoethanol 2 mM, and PMSF 1 mM) with lysozyme. This was followed by centrifugation. The clarified supernatant was mixed with freshly recharged Ni-NTA (Nickel-Nitrilotriacetic acid) agarose beads. The beads were eluted with lysis buffer containing 300 mM imidazole. The imidazole was removed by using dialysis membrane overnight with Tris-Cl (50 mM) pH 8.0, NaCl (150 mM), and DTT (2 mM) for further use of protein.

Plaque Assay
The viral titration was done using plaque assay as per previously published protocol [39]. Briefly, the medium was replaced with serum-free medium 1 h prior to infection. The medium collected from CHIKV-infected Aag2 cells were initially diluted at 1:10 and added to the first well in triplicates, and then was diluted at 1:2 in the rest of the wells. The virus was allowed to bind to the cells for 90 min, and then the serum-supplemented medium was added. The wells were then added with 1% carboxymethyl cellulose (CMC) (Sigma-Aldrich, St. Louis, MO, USA, Cat. no. C4888) and plates were transferred back to the 5% CO 2 supplemented humidified incubator at 37 • C for 72 h. The cells were fixed with paraformaldehyde for 1 h. After fixing, crystal violet stain (0.25%) was added to the wells and incubated for 30 min. The stain solution was discarded and wells were rinsed with tap water. The plaques were calculated as plaque-forming units (pfu) = (number of plaques)/(dilution × volume of the virus).

In Vitro PARylation Assay and Co-Incubation Assay with CHIKV nsP3 Protein
The in vitro assay was performed following previous protocol [40]. The E. coli purified recombinant tankyrase protein (8 to 12 µg) was incubated for the specified time at 28 • C in PARP reaction buffer (50 mM Tris-Cl [pH 8.0], 4 mM MgCl 2 , 0.2 mM DTT (dithiothreitol) containing 25 µM beta-Nicotinamide adenine dinucleotide sodium salt (NAD+) (Sigma-Aldrich, St. Louis, MO, USA, Cat. no. N0632-1G). The reactions were terminated by adding SDS loading buffer, and 4-6 µg of each protein sample was fractionated by 10% SDS-PAGE. The proteins were transferred onto a nitrocellulose membrane and probed with anti-pADPr antibody (10H) (Santa Cruz, USA, Cat. no. sc-56198 1:2000 dilution). The membrane was then probed with anti-mice IgG HRP antibody (Novus Biologicals, Centennial, CO, USA, Cat. no. NB7539) and visualized in a Bio-Rad ChemiDoc MP System after brief exposure to chemiluminescent substrate. Similar to the in vitro PARylation assay, the nsP3 co-incubation assay was carried out. The purified recombinant CHIKV nsP3 protein (8 to 12 µg) was added to the reaction mixture for the desired time and the reaction was stopped by adding SDS loading buffer. The 4-6 µg of each sample were then separated by SDS-PAGE, transferred onto the nitrocellulose membrane, and probed with anti-pADPr antibodies, followed by exposure to chemiluminescent substrate and visualization in ChemiDoc MP system.

In Vitro Transcription, RNA Isolation and Real-Time PCR
For double stranded RNA synthesis, T7 sequence (Tankyrase forward primer 5 -TAATACGACTCACTATAGGGTCACCGAACTGCTCATCAAG-3 , reverse primer 5 -TATCCGAAGCGAAAGCAAGTCCCTATAGTGAGTCGTATTA-3 , EGFP forward primer 5 -TAATACGACTCACTATAGGGATGGTGAGCAAGGGCGAGG-3 , and reverse primer 5 -TAATACGACTCACTATAGGGCTTGTACAGCTCGTCCATGCC-3 ) was added to the primer and the desired product of around 400 bp was amplified using Dream Taq DNA polymerase (Thermo Fisher Scientific Inc., Waltham, MA, USA, Cat. no. EP0701) following the manufacturer's protocol. The PCR product was purified and an in vitro reaction was setup using MEGAscript T7 transcription kit (Thermo Fisher Scientific Inc., Waltham, MA, USA, Cat. no. AM1334) following the manufacturer's protocol. The dsRNA after in vitro transcription was treated with TURBO DNase. The RNA was purified using TRIzol reagent. Whole cell RNA isolation from Aag2 cells was done following previous protocol [41]. Total cellular RNA was isolated using TRIzol (Thermo Fisher Scientific Inc., Waltham, MA, USA). RNA was dissolved in DEPC treated water and quantified. One-step SYBR green real-time PCR was carried out on PIKOREAL 96 Well real-time PCR system (Thermo Fisher Scientific Inc., Waltham, MA, USA). A total of 300 ng total RNA per reaction was used with 0.3 µM of each primer with QuantiTect PCR kit (Qiagen, Hilden, Germany). The RT-PCR conditions for the one-step RT-PCR consisted of a 30 min reverse transcription step at 50 • C and then 2 min of initial denaturation at 95 • C, followed by 40 cycles of PCR at 95 • C without holding time (denaturation), 60 • C for 30 s (annealing), and 72 • C for 30 s (extension). Small subunit ribosomal protein 7 (RPS7) was used as an internal control. Tankyrase real-time PCR sequence used forward primer 5 -GGTGAAGAACCTCGAGAAAGAA-3 and reverse primer 5 -CAATAGCAGCAAAGCTGGAAC-3 and RPS7 forward primer 5 -CCCGGTTGACGATGGATTT-3 and reverse primer 5 -TCACGAAACCAGCGATCTTATT-3 .

Immunofluorescence Assay
Aag2 cells were cultured in 6 well plates containing sterile glass coverslips. Cells were infected with CHIKV at MOI 1 for 24 h and 48 h. The cells were then fixed with 4% paraformaldehyde for 30 min and then permeabilized using 0.1% Triton-X-100 for 30 min. Cells were then blocked with bovine serum and then incubated with anti-CHIKV nsP3 rabbit serum [38] at 1:200 dilution in PBS (phosphate buffer saline) + 2.5% BSA overnight. The following day, washing was done using PBST (PBS + 0.1% tween-20) 3 × 10 min. The cells were then added with a secondary antibody (anti-mice IgG Alexa 594) at 1:400 dilution. This was followed by washing with PBS + 0.1% tween-20 for 3 × 10 min. The cells were immersed in DAPI for a few minutes and then visualized in Nikon eclipse confocal microscope (Nikon Corp, Tokyo, Japan) with oil immersion for magnification.

Statistical Analysis and Software
Statistical analyses for plaque assay analysis and real-time PCR were performed using two-way ANOVA. The analyses were done using Graphpad prism software (version 9.1.1).

Identification of ADP-Ribose Polymerases in Ae. aegypti
In order to compare the proteins in Ae. aegypti to the 17 human PARPs, sequence alignment was performed using blast tool (Blastp, NCBI). The results showed that Ae. aegypti encodes for three ADP-ribose polymerases, which are as follows: (1) tankyrase (NCBI accession: XP_021708496.1), (2) Poly ADP-ribose polymerase (PARP; NCBI accession: XP _001661932.1), and (3) Mono-ADP-ribose polymerase (MARP; NCBI accession: XP _001647568.1). The phylogenetic sequence analysis showed that the Ae. aegypti tankyrase protein was showing the highest sequence similarity to human PARP5a and PARP5b, and the Ae. aegypti PARP protein had the highest sequence similarity to human PARP1, while the Ae. aegypti MARP protein was showing the highest sequence similarity to human PARP16 ( Figure 1A). These three ADP-ribose polymerases differed from one another in terms of the various sorts of domains. Here is the domain analysis for the three proteins:

1.
Tankyrase: Tankyrase-1 (PARP5a) and tankyrase-2 (PARP5b) in human were found to be closest to Ae. tankyrase among the 17 human PARPs ( Figure 1A). Three different types of domains were identified by the domain analysis: Ankyrin repeats, SAM domains, and PARP catalytic domains ( Figure 1B). The 30-35 amino acid long motifs known as ankyrin repeats, which have a helix-turn-helix shape, are essential for protein-protein interactions [41,42]. Protein-protein interactions are mediated by another domain called the sterile alpha motif (SAM). These play a role in oligomerization as well as binding [43]. ADP-ribose is added by the third domain, called the PARP catalytic domain. Sequence alignment of tankyrase and PARP5b revealed an Ankyrin repeat region, which is crucial for protein-protein interaction and PARP catalytic domain, which is responsible for ADP-ribosylation activity, exhibited a higher region of similarity ( Figure S2).

2.
PARP: A poly ADP-ribose polymerase called PARP is the other protein found in Ae. aegypti. The most resemblance between Ae. aegypti PARP and human PARP1 was found during the phylogenetic analysis ( Figure 1A). According to domain analysis, there are different types of domains: PARP Zn, BRCT, PARP alpha, and PARP catalytic domain ( Figure 1B). A zinc finger domain, PARP Zn, included two copies. These proteins, which typically reside in the nucleus, are implicated in DNA repair [44]. The BCRT (BRCA1 C-terminus) domain was the second domain from the protein's N-terminal. When the PARP alpha domain binds to the site of DNA damage, it transmits the activation signal [45]. The sequence alignment of PARP with PARP1 revealed several amino acid similarities between these two proteins, with the PARP catalytic domain showing the highest degree of similarity, indicating that this domain is mostly conserved in these animals ( Figure S3). All of these facts suggest that the Aedes PARP protein is an enzyme that repairs DNA damage.

3.
MARP: Mono-ADP-ribose polymerase (MARP) is responsible for adding mono-ADPribose units to proteins. These proteins cannot further connect ADP-ribose subunits to the terminals of those already attached [46]. According to the results of the phylogenetic research, the human MARP protein PARP16 and the Ae. aegypti MARP have the highest degree of similarity ( Figure 1A). Proteins share comparable amino acids in the region responsible for catalytic activity of the protein, as seen by the sequence alignment of MARP and PARP16 ( Figure S4). The MARP protein from Ae. aegypti is 362 amino acids long and only comprises a catalytic domain ( Figure 1B), suggesting that it may be used for priming proteins or for MARylating proteins that are either activated or inactivated upon MARylation.
Based on analysis and evidence from the literature, we came to the conclusion that tankyrase is responsible for attaching the ADP-ribose chain to proteins, PARP is responsible for DNA repair, and MARP is responsible for intracellular signaling or priming. As the Ae. aegypti tankyrase protein contained a region implicated in protein-protein interaction, we moved forward with its cloning, production, purification, and characterization. These kinds of proteins are crucial for controlling cellular functions, and their discovery and characterization may shed light on the intricate mechanisms governing numerous biological processes. Full-length PARP proteins are required for the PARylation of target proteins in cells [47][48][49], but the catalytic domain alone is sufficient to create ADP-ribose chains on the proteins [49]. The catalytic domain of Ae. aegypti tankyrase protein ( Figure 1B) was cloned into pET32a vector. The purified protein (of 60 kDa (kilo Dalton) size) was expressed in soluble form and was checked for purity using Coomassie stain and western blot ( Figure 1C).

In Vitro PARylation Assay of Catalytic Domain of Tankyrase Protein and Impact of nsP3 Macrodomain
Each of the several domains that make up the PARP proteins is essential for their proper function in cells. Target proteins are added with long, variable-length ADP-ribose chains by these PARPs (Figure 2A) [15,16,50]. In this study, the capacity to add ADP-ribose subunits was initially assessed in the catalytic domain of tankyrase proteins. The tankyrase alone ( Figure 3B, lane 1) and NAD + ( Figure 2B, lane 2) as well as CHIKV capsid protein ( Figure 2B, lane 3) were employed as a negative control (for a non-specific signal). The presence of tankyrase catalytic domain resulted in an intense band of higher molecularweight proteins ( Figure 2B, lane 4), indicating that tankyrase domain was using NAD + as a substrate to add ADP-ribose to itself via mechanism called auto-PARylation ( Figure 3A). At both 30 min and 60 min, the PARylation assay revealed that the protein had undergone ADP-ribose modification with various lengths of the PAR chain ( Figure 2C).
The in vitro PARylation assay showed that catalytic domain of tankyrase could add ADP-ribose units. Previous work from lab by Mathur et al. [51] has shown that CHIKV nsP3 macrodomain act as a viral suppressor of RNAi. CHIKV macrodomain is a mono-ADPribosylhydrolase and is crucial for the viral replication [28,52]. We were curious to find out if the CHIKV macrodomain, which is known to remove mono-ADP-ribose moieties [52], affected the poly ADP-ribosylation of proteins caused by Ae. aegypti PARPs. The bacterially purified CHIKV nsP3 protein ( Figure S5) was added to the PARylation reaction mixture, and the reaction was run for 30 and 60 min in order to assess the function of the nsP3 macrodomain on ADP-ribosylation. Following the incubation of the nsP3 protein, it was found that the PARylation decreased as the incubation duration increased up to 60 min. In comparison to the 30 min and 60 min of the PARylated samples alone, the number or length of the PAR chains was lower at 30 min following the incubation of the nsP3 protein and dramatically decreased at 60 min ( Figure 2D). The knockdown of tankyrase gene by dsRNA transfection resulted in increased titer of CHIKV ( Figure 2E).  tein ( Figure 2B, lane 3) were employed as a negative control (for a non-specific signal). The presence of tankyrase catalytic domain resulted in an intense band of higher molecularweight proteins ( Figure 2B, lane 4), indicating that tankyrase domain was using NAD + as a substrate to add ADP-ribose to itself via mechanism called auto-PARylation ( Figure 3A). At both 30 min and 60 min, the PARylation assay revealed that the protein had undergone ADP-ribose modification with various lengths of the PAR chain ( Figure 2C).   4) and (E) dsRNA mediated knockdown aegypti tankyrase transcript. Aag2 cells were transfected with dsRNA for tankyrase and EGFP trol) for 24 h and then infected with CHIKV at MOI of 1. Cells were collected at 24 hpi and and viral titer was quantified by CHIKV E1 specific primers using real-time PCR and plaque ns-non-significant, * p-value <0.05 ** p-value < 0.001 and **** p-value < 0.0001. The in vitro PARylation assay showed that catalytic domain of tankyrase coul ADP-ribose units. Previous work from lab by Mathur et al. [51] has shown that C nsP3 macrodomain act as a viral suppressor of RNAi. CHIKV macrodomain is a m ADP-ribosylhydrolase and is crucial for the viral replication [28,52]. We were curio find out if the CHIKV macrodomain, which is known to remove mono-ADP-ribose ties [52], affected the poly ADP-ribosylation of proteins caused by Ae. aegypti PARP bacterially purified CHIKV nsP3 protein ( Figure S5) was added to the PARylation rea mixture, and the reaction was run for 30 and 60 min in order to assess the function nsP3 macrodomain on ADP-ribosylation. Following the incubation of the nsP3 prot (C) Aag2 transfected with EGFP and macrodomain were infected with CHIKV at MOI of 1 for 24, 36, and 48 hpi. The medium was collected and used for viral titration via plaque assay, error bars represent standard deviation (sd). n = 4 (triplicates), and (D) Western blot of EGFP and macrodomain transfected cells infected with CHIKV at MOI of 1 after 48 hpi. The membrane was blotted with antibodies for CHIKV E1, actin, and V5 tag. ns-non-significant, * p-value < 0.05.

Effect of CHIKV nsP3 Macrodomain on PARylation Activity of Tankyrase
In CHIKV-infected Aag2 cells, the effect of the macrodomain alone on viral replication was also investigated. The nsP3 protein form discrete granules in cells, called replication complexes, and the number of cells increases with infection time (Figure S6), indicating that the nsP3 protein is not uniformly present in cells. To evaluate the impact of the macrodomain in viral kinetics, EGFP and the CHIKV macrodomain were cloned in the pIB/V5-His vector ( Figure 3A) and transfected into Aag2 cells. The lysates were separated on SDS-PAGE gel and incubated with an anti-pADPr antibody. In all conditions of CHIKV infection (alone, with EGFP, or macrodomain transfected cells), PAR levels were increased compared to uninfected cells and transfected cells ( Figure 3B). The global cellular PAR level difference between EGFP and macrodomain transfected cells was not significant. In plaque assay, we observed that the viral titer was high in macrodomain transfected cells compared to control (EGFP transfected) at 24 and 36 hpi, but at 48 hpi the difference between control and macrodomain was small ( Figure 3C). At 24 hpi, western blot examination of CHIKV E1 protein revealed a similar pattern. CHIKV expression was lower in cells transfected with EGFP (lane 1) than it was in cells transfected with macrodomain (lane 2) ( Figure 3D).

Discussion
ADP-ribosylation is an important PTM of proteins and nucleic acids that is mediated by PARPs. DNA repair, cell signaling, stress response, pathogen response, and gene control are just a few of the functions that PARPs are engaged in [49]. By targeting cellular transcripts, encouraging apoptosis [53], attenuating RISC (RNA induced silencing complex) mediated transcript silencing [54], inducing interferon-stimulated genes (ISGs), and degrading viral proteases, PARPs provide antiviral functions during viral infections [55]. In the current study, the sequence alignment with human PARPs led to the identification of three Ae. aegypti PARP proteins, including tankyrase (PARP5b), PARP (PARP1), and MARP (PARP16). Among these, tankyrase catalytic domain was cloned, expressed, and purified in a bacterial system. By using an in vitro PARylation assay, it was discovered that the tankyrase catalytic domain add PAR chains of variable length to its own molecules (auto-PARylation). The phosphate residues in the PAR chains imparts a negative charge, which interacts with the candidate proteins' PAR binding motif (PBM) [56]. The length and degree of branching impacts the propensity to create multimeric complexes [50,57] and also affects cellular systems [15]. Knockdown of tankyrase led to higher viral titer, indicating that there might be other PARP isoforms that are involved in the immunity against viruses, or tankyrase is involved in the inactivation of viral proteins, hence its knockdown increasing the viral titer. A recent study highlights that mono-ADP-ribosylation of viral protein (nsP2) by host PARP leads to inhibition of nsP2 enzymatic activity [34], raising the possibility that a similar protein might be playing a role in providing immunity to mosquito cells against viral infection.
The fact that the active macrodomain of an alphavirus is conserved in the active site region shows how crucial the active macrodomain is for viral life [32]. According to earlier research, mutation in the active areas influences viral replication [28,32]. The results of the current study demonstrated that CHIKV infection leads to increased PARylation of the cellular proteome, but nsP3 macrodomain transfection did not affect the global PARylation compared to the EGFP control. During infection, nsP3 protein is present as discrete granules in the cells, indicating that it may not be interacting with the whole host proteome but instead only a limited number of proteins. Transfection of nsP3 macrodomain significantly reduced viral titer, suggesting that the macrodomain prevents PAR-chain formation by hydrolyzing ADP-ribose. Based on our data, we proposed a model hypothesis that host PARP proteins are either ADP-ribosylate host or viral proteins which leads to the inhibition of viral replication (by activation of immune pathways or inhibition of crucial viral protein activity). To counter the host immune mechanism, the viral macrodomain removes ADPribose from the host or viral proteins, leading to an inactivation of host immune pathways or resumption of viral protein activity ( Figure 4). Further in-depth studies are essential to identify and characterize other host targets and modes of action of macrodomain on modulating host/viral protein functions. significantly reduced viral titer, suggesting that the macrodomain prevents PAR-chain formation by hydrolyzing ADP-ribose. Based on our data, we proposed a model hypothesis that host PARP proteins are either ADP-ribosylate host or viral proteins which leads to the inhibition of viral replication (by activation of immune pathways or inhibition of crucial viral protein activity). To counter the host immune mechanism, the viral macrodomain removes ADP-ribose from the host or viral proteins, leading to an inactivation of host immune pathways or resumption of viral protein activity ( Figure 4). Further in-depth studies are essential to identify and characterize other host targets and modes of action of macrodomain on modulating host/viral protein functions. . Proposed model of mechanism of tankyrase-mediated PARylation and CHIKV nsP3 macrodomain-mediated de-ADP-ribosylation of host/viral proteins. We hypothesize based on literature as well as current evidence that ADP-ribosylation inhibits viral growth by activating immune pathways or inactivating crucial viral proteins and thus reduces viral titer. CHIKV nsP3 has strong de-MARylation and weak de-PARylation activity. This indicates that nsp3 macrodomain either removes ADP-ribose from viral proteins, thereby preventing their inactivation or from host proteins thus inhibiting their role in immune pathways and crucial metabolic processes. This eventually leads to increased viral titer and compromised host immune system.
Supplementary Materials: The following supporting information can be downloaded at: www.mdpi.com/xxx/s1, Figure S1: Uncropped images of SDS-PAGE gel, ponceau stained and chemiluminescent substrate exposed membranes used in the study.; Figure S2: Sequence alignment of Ae. aegypti Tankyrase proteins and human PARP5b protein.; Figure S3 Sequence alignment of Ae. aegypti PARP protein and human PARP1 protein.; Figure S4: Sequence alignment of Ae. aegypti . Proposed model of mechanism of tankyrase-mediated PARylation and CHIKV nsP3 macrodomain-mediated de-ADP-ribosylation of host/viral proteins. We hypothesize based on literature as well as current evidence that ADP-ribosylation inhibits viral growth by activating immune pathways or inactivating crucial viral proteins and thus reduces viral titer. CHIKV nsP3 has strong de-MARylation and weak de-PARylation activity. This indicates that nsp3 macrodomain either removes ADP-ribose from viral proteins, thereby preventing their inactivation or from host proteins thus inhibiting their role in immune pathways and crucial metabolic processes. This eventually leads to increased viral titer and compromised host immune system.

Supplementary Materials:
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/pathogens12050718/s1, Figure S1: Uncropped images of SDS-PAGE gel, ponceau stained and chemiluminescent substrate exposed membranes used in the study.; Figure S2: Sequence alignment of Ae. aegypti Tankyrase proteins and human PARP5b protein.; Figure S3 Sequence alignment of Ae. aegypti PARP protein and human PARP1 protein.; Figure S4: Sequence alignment of Ae. aegypti MARP protein and human PARP16 protein.; Figure S5: Coomassie brilliant blue stained SDS-PAGE gel and western blot of bacterial purified recombinant nsP3 protein.; Figure S6: Immunofluorescence assay of CHIKV infected Aag2 cells.